Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06900881Phase 3Recruiting
Phase 3, randomised, triple-blind trial (2 arms), sponsored by Al-Mustansiriyah University. Primary endpoints: Gingival Index (GI) at 28 days, Plaque Index (PI) at 28 days and 2 more. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06900881.